Balanced news tone
News Sentiment
1177 sentiment intelligence
Sino Biopharmaceutical Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
92/100 classification confidence.
directly relevant articles
high-authority source matches
+9.5% over one week, +11.7% over four weeks, trend inactive, and near fair-value range.
Sino Biopharmaceutical's Stock Price Drops to 4.98 HKD, Slumps by 5.32% in Recent Market Performance
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Sino Biopharmaceutical's Stock Price Drops to 4.98 HKD, Slumps by 5.32% in Recent Market Performance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 08:41
- Source
- Smartkarma
Sino Biopharmaceutical Stock Climbs 2.3% in Hong Kong
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 09:44
- Source
- Moomoo
Sino Biopharmaceutical’s Stock Price Soars to 5.25 HKD, Marking a Robust 2.74% Increase
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 08:37
- Source
- Smartkarma
Sino Biopharmaceutical's Stock Price Drops to 5.17 HKD, Recording a 0.39% Decline: A Deep Dive into its Market Performance
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 13 Jul 2026 08:36
- Source
- Smartkarma
ETFs Investing in Sino Biopharmaceutical Limited Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 20:02
- Source
- TradingView
Why Sino Biopharmaceutical (SEHK:1177) Is Up 8.2% After New Global Respiratory Deals And NDA Milestone
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 23:58
- Source
- simplywall.st
AstraZeneca secures ex-China license for Sino Biopharmaceutical's experimental COPD drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 07:00
- Source
- Reuters
Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 05:21
- Source
- WTVB
Sino Biopharmaceutical (SEHK:1177) Advances Pipeline As Valuation Signals Stay Mixed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 20:44
- Source
- simplywall.st
Sino Biopharmaceutical Ltd stock (KYG8087W1029): Hepatitis B partnership with GSK highlights China f
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 16 May 2026 07:00
- Source
- ad-hoc-news.de
Sino Biopharmaceutical Limited's (HKG:1177) largest shareholder, CEO S. Y. Tse sees holdings value fall by 7.4% following recent drop
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 24 Nov 2025 08:00
- Source
- simplywall.st